期刊文献+

无抗性表达致PWD和ED大肠杆菌保护性抗原基因的重组菌构建 被引量:2

Construction of Non-antibiotic Recombinant Strain Expressing the Major Protective Antigens of Shiga-like Toxigenic Escherichia coli Caused PWD and ED
下载PDF
导出
摘要 利用平衡致死系统成功地将构建表达致PWD和ED大肠杆菌保护性抗原基因的重组菌BL21(pFSFaeG)中所含氨苄抗性基因敲除,并转化沙门氏菌宿主菌X4550。经过质粒酶切分析和表达产物的SDSPAGE证实,氨苄抗性基因已经成功敲除,并且目的蛋白仍与谷胱甘肽转移酶相融合,得到有效表达,重组融合蛋白的分子质量约为80ku。经体外连续传代试验,重组菌X4550(pFSFaeG)均能在无抗生素压力下大量扩增并稳定传代,质粒稳定性和蛋白表达稳定性良好。无抗性重组菌的成功构建解决了基因工程疫苗抗性基因潜在危险问题,并有望通过沙门氏菌载体的递送作用,为研制口服疫苗奠定了基础。 By introducing asd gene from sallmonella typhimurium into a prokaryotic expression plasmid vector of E.coli and destroying ampicillin resistance gene at the same time, a new prokaryotic expression recombinant strain which contained no antibiotic resistance gene was constructed .It was based on the recombinant strain BL21(pFSFaeG) which contained ampicillin resistance gene.Restriction endonuclease analysis was used to indentify the new recombinant plasmid.The results indicated that the plasmid was correctly constructed and the ampicillin resistance gene was koncked out.Partly soluble GST-FedA-Stx2eB-FaeG fusion protein was expressed in recombinant strain X4550 (pFSFaeG) after induced by IPTG at 37 ℃, which was confirmed by SDS-PAGE analysis.The new recombinant strain can be amplified in large amount in vitro without the need of antibiotic pressure.The stability of plasmid and expression of protein were confirmed very well, which constituted a solid foundation for the further study of oral immunization.
出处 《动物医学进展》 CSCD 2005年第7期45-48,68,共5页 Progress In Veterinary Medicine
基金 江苏省高技术研究计划资助(No.BG2002316)
关键词 平衡致死系统 基因敲除 蛋白表达 balanced-lethal system gene konck out protein expression
  • 相关文献

参考文献4

二级参考文献26

  • 1钱锋,芮贤良,苏国富,黄翠芬.宋内Ⅰ相O抗原及霍乱毒素B亚基在福氏2a痢疾菌中的表达及其免疫保护效果的观察[J].Acta Genetica Sinica,1996,23(4):322-328. 被引量:4
  • 2李德玲,苏国富,芮贤良,黄翠芬.宋内Ⅰ相抗原和霍乱CT-B共表达的免疫保护效果观察[J].生物工程学报,1996,12(1):78-83. 被引量:4
  • 3余风刚.霍乱弧菌thyA致死平衡系统的构建及病毒来源蛋白的表达[J].中国预防医科院博士生毕业论文,1999.13 被引量:1
  • 4Yu Daiguan, Hilary M. Ellis E, et al. An efficient recombination system for chromosome engineering in Excherichia coli [J].Proc Nail Acad Sci USA, 2000, 97(11):5978 被引量:1
  • 5Belfort M, Maley GF, Maley F. Characterization of the Escherichia coli thyA gene and its amplified thymidylate synrthetase product[J]. Proc Nail Acad Sci USA, 1983,80:185 被引量:1
  • 6Belfort M, Maley GF, Pedersen-Line J. Primary structure of the Escherichia coli thyA gene and its thymidylate synthase product[J]. Proc Natl Acad Sci USA, 1983,80:4914 被引量:1
  • 7Fu X, Xu JG. Development of a chromosome-plasmid balanced lethal system for Lactobacillus acidophilus with thyA gene as selective marker[J]. Microbiol Immunol, 2000,44(7): 551 被引量:1
  • 8Ryan ET, Crean TI, Kochi SK, et al. Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae[J]. Infect Immunol, 2000, 68(1): 221 被引量:1
  • 9Gan Keda, Krishnan Sankaran, Williams MG, et al. The umpA gene of Escherichia coli encodes phosphatidylglycerol: Prolipoprotein diacylglyceryl transferase (lgt) and regulates thymidylate synthase levels through translational coupling[J]. J Biochem,1995, 1879 被引量:1
  • 10Nayak AR, Tinge SA, Tart RC, et al. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcai surface protein A induces protective responses against Streptococcus pneumoniae[J]. Infect Immun, 1998, 66(8): 3744 被引量:1

共引文献26

同被引文献13

  • 1卞继峰,于修平,耿昭,卢翌,胡海燕,王伟,王晓明.HPV16重组减毒沙门氏菌表达质粒的构建及其诱导免疫[J].中国病毒学,2005,20(2):108-112. 被引量:1
  • 2赵德明 张仲秋 沈建忠.猪病学 [M](第8版)[M].北京:中国农业出版社,2000.. 被引量:1
  • 3Macleod D L, Gyles C L. Purification and characterization of Escherichia coli shiga-like toxin Ⅱ variant [J]. Infect Immun, 1990, 58: 1232-1239. 被引量:1
  • 4Macleod D L, Gyles C L. Imumunization of pigs with a purified shiga-like toxinⅡ variant toxoid [J]. Vet Micr-obiol, 1991, 29: 309-318. 被引量:1
  • 5Hormaeche C E, Khan C M, Villarreal B, et al. Salmonella vaccines: Mechanisms of immunity and their use as carriers of recombinant antigens [A]. In: Ala' Aldeen A A, Hormaeche C E. Molecular and Clinical Aspects of Bacterial Vaccine Development [C]. Chichester: John Willey and Sons, 1995. 155-178. 被引量:1
  • 6Wu S, Pascual D W, Vaneott J L, et al. Immune response to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen Ⅰ(CFAⅠ) of enterotoxigenic E.coli in the absence of the CFA/Ⅰpositive regulator cfa R [J]. Infect Immun, 1995, 63: 4933-4938. 被引量:1
  • 7Ascon M A, Hone D M, Walters N, et al. Oral immunization with a Salmonella typhimurium vaccine vector expr-essing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity [J]. Infect Immun, 1998, 66: 5477-5484. 被引量:1
  • 8Neumann E, Oliveira MA, Cabnd CM, a al. Monoassociation with Lactobacillus acidophilus UFV-H2b20 stimulates the immune defense mechanisms of germfree mice [ J]. Braz J Med Bid Res, 1998, 31 (12):1 565- 1 573. 被引量:1
  • 9Bermudez Humaran LG, Langella P, Cortes Perez NG, et al.Intranasal immunization with recombinant Lactococcus lactis secreting murine intedeukin-12 enhances antigen-specific Th1 cytokine production [ J ]. Infect Immun, 2003, 71 ( 4 ) :1 887- 1 896. 被引量:1
  • 10Garmory HS, Leary SE, Griffin KF, et al. The use of live attenuated bacteria as a delivery system for heterologous antigens[J]. J Drag Target, 2003, 11 (8/10):471-479. 被引量:1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部